American Samoa vs Cambodia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
American Samoa
0.4%
in 2024
Cambodia
0.4%
in 2024
American Samoa rank
59th
Cambodia rank
59th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- American Samoa
- Cambodia
How they compare
American Samoa currently reports 0.4% against 0.4% in Cambodia, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Cambodia ahead.
American Samoa ranks 59th and Cambodia ranks 59th of 215 countries.
American Samoa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | American Samoa | Cambodia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.4% | 0.0% | American Samoa |
| 2020s | 0.5% | 0.4% | 0.1% | American Samoa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, American Samoa or Cambodia?
- American Samoa, at 0.4% against 0.4% in Cambodia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between American Samoa and Cambodia?
- 0.0%, with American Samoa ahead.
- How many years of comparable data are there for American Samoa and Cambodia?
- 10 years are reported by both, from 2015 to 2024.
- How do American Samoa and Cambodia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- American Samoa ranks 59th and Cambodia ranks 59th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.